Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Don’t Even Think About Buying the Rally in AMC Entertainment

Some traders celebrated as the cash-strapped theater chain issued a massive amount of debt, but that's not a great reason to buy AMC stock.

For Nikola, Valuation and Financial Analysis Argue to Stay Away

NKLA stock is a high-risk bet, as the company has legal troubles, no revenue, and trades on hopes to revolutionize the hydrogen economy.

Boeing Stock Still Has Too Long a Recovery to Make a Big Comeback Soon

Investors should keep an eye on Boeing for signs of whether CEO David Calhoun is turning the company around.

There Are Troubling Signs That Boeing Stock’s About To Lose Altitude

Boeing stock's space and defense catalysts have kept cash flowing during the pandemic. But BA stock could come down to earth as its biggest space customer rethinks priorities.

Secretive EV Battery Maker QuantumScape Is a Stock to Avoid

QuantumScape is garnering a lot of attention. But the risks of buying QS stock far outweigh the potential rewards right now.

Advanced Micro Devices Is Priced Too High for Value Investors

Advanced Micro Devices shares may not offer value. AMD stock trades for 47 times 2021 earnings, which is too high for value investors.

Ocugen Is Hanging On By a Thread With Its Latest Indian Biotech Deal

Ocugen is hanging on by a thread with its latest Indian biotech deal. OCGN stock looks to be a highly speculative play with a negative expected return.

You Need to Sell Fuel Cell Stock Now, Before Everyone Else Does

FuelCell Energy is temporarily riding the momentum higher as investors buy anything that has clean energy attached to its business.

The EV Bubble Keeping Nio Stock Afloat Needs a Sharp Pin Prick of Reality

Electric cars are defined by battery technology, and Nio's battery swaps are five years behind Tesla technology which makes the battery part of the car body. NIO stock needs a pin prick of that reality.

Analyst Downgrades and Other Red Flags Are Bearish for Palantir

Palantir's products appear to lack strong differentiation and PLTR stock is trading at high valuations, so the shares remain a sell.

Facebook Stock Has One Major Like, But Plenty of Dislikes

Facebook stock gets a "like" for its dominant position in social media. However, the company has too many risks fo investors to ignore.

Don’t Buy Overvalued and Speculative SPACs Like IPOD Stock

Don't buy overvalued SPACs like IPOD stock. IPOD stock trades for over 75% more than its IPO price even though there is no merger deal.

Zomedica Pharmaceuticals Is Mostly Hype

Zomedica Pharmaceuticals is likely a pump-and-dump. Don't get caught holding the bag when ZOM stock crashes back to under $1 per share.

The S&P 500 Won’t Be Spared If This Market Is in a Bubble

While tech has gotten the attention, the S&P 500 has posted an impressive rally of its own. If investors get nervous, this index too will suffer.

No Market Share Makes Naked Brands a Bad Bet

With no immediate threat of delisting, speculators have a few more months to spin the wheel on NAKD stock. But without real revenue, that's a bad bet.

3 Real Estate Stocks Suffering Under the NY Eviction Ban

These three real estate stocks are having it rough amidst the extension of the anti-eviction ban in New York.

Why You Should Check Out of Airbnb Stock Before It Gets Wild

While Airbnb stock seems to have the right stuff as a disrupter, the pandemic could give ABNB a taste of its own medicine.

This S&P 500 ETF Stock Is Way Less Reliable Than You Know

SPY stock tracks the S&P 500 well, but it's too heavily weighted towards momentum stocks and under-represents value plays.

Ocugen Stock Looks Overinflated

Celebrating Ocugen's value-added collaboration to develop a potentially lifesaving vaccine is fine, but OCGN stock might be too pricey now.